t
JPMorgan European Growth & Income PLC announced its ten largest investments as a percentage of total assets on 13 January 2026. As at 31 December 2025, the top holdings included Asml (4.0%), Novartis (3.5%), and Roche Holdings (3.5%). These ten investments combined represented 27.6% of total assets, excluding liquidity stocks, with other individual holdings ranging down to 2.1%.
| Date | 13 Jan 2026 |
| Time | 15:56:43 |
| Category | Corporate updates |
| ID | 7522O |
|
JPMORGAN EUROPEAN GROWTH & INCOME PLC (the 'Company') |
|
|
Legal Entity Identifier: 549300D8SPJFHBDGXS57 |
|
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 December 2025 |
|
|
Asml |
4.0% |
|
Novartis |
3.5% |
|
Roche Holdings |
3.5% |
|
Nestle |
2.6% |
|
Siemens |
2.4% |
|
Unicredit SPA |
2.4% |
|
JPMorgan European Discovery Trust Plc |
2.4% |
|
Banco Santander |
2.4% |
|
Allianz |
2.4% |
|
Safran Sa |
2.1% |
|
Total |
27.6% |
|
Excludes Investments in Liquidity stocks |
|
|
Name of contact and telephone number for queries: |
|
|
Paul Ainger 0044 207 742 6524 |
|
|
Name of authorised company official responsible for making this notification: |
|
|
Paul Winship 0044 207 742 9815 - Company Secretary |
|
|
Date: 13 January 2026 |
|
|
|
|